report
case
fatal
pneumonia
viremia
due
human
parainfluenza
viru
type
male
patient
adult
tcell
leukemiaelymphoma
atl
treat
mogamulizumab
brandnew
therapeut
agent
atl
knowledg
first
report
describ
viremia
due
administ
mogamulizumab
lymphocyt
count
blood
drastic
decreas
patient
suffer
complic
infect
includ
gramneg
bacteri
sepsi
cytomegaloviru
antigenemia
aspergillosi
although
infect
success
control
broad
spectrum
antimicrobi
therapi
patchi
groundgrass
opac
lung
gradual
worsen
final
die
due
acut
respiratori
failur
sinc
find
chest
ct
consist
typic
pattern
viral
pneumonia
screen
major
respiratori
virus
peripher
blood
multiplex
pcr
turn
rna
posit
although
atl
cell
detect
autopsi
lung
varieti
tissu
cytoplasm
inclus
bodi
commonli
observ
rna
viral
infect
abundantli
observ
autopsi
lung
tissu
find
suggest
mogamulizumab
accomplish
complet
remiss
atl
chemotherapyinduc
prolong
lymphopenia
caus
fatal
pneumonia
viremia
due
well
recogn
commun
respiratori
virus
includ
often
caus
fatal
pneumonia
patient
leukemia
also
specif
treatment
enforc
standard
precaut
especi
treat
leukem
patient
intens
immunosuppress
agent
mogamulizumab
adult
tcell
leukemiaelymphoma
atl
kind
peripher
tcell
lymphoma
caus
human
tcell
lymphotrop
viru
type
classifi
four
categori
acut
lymphoma
chronic
smolder
type
depend
clinic
featur
atl
often
resist
chemotherapi
thu
result
poor
prognosi
sinc
atl
per
se
induc
sever
impair
cellular
immun
atl
patient
suscept
opportunist
infect
cytomegaloviru
cmv
candida
pneumocysti
jirovecci
strongyloid
stercorali
mogamulizumab
promis
brandnew
therapeut
option
atl
agent
bind
cec
chemokin
receptor
protein
abundantli
express
membran
surfac
atl
cell
therebi
activ
natur
killer
cell
manner
antibodydepend
cellular
cytotox
patient
treat
mogamulizumab
median
progressionfre
surviv
overal
surviv
interv
month
respect
hand
profil
robust
cytotox
would
problemat
case
fact
suggest
mogamulizumab
increas
risk
reactiv
cmv
hepat
b
viru
commun
respiratori
virus
crv
human
rhinoviru
parainfluenza
viru
caus
common
cold
healthi
subject
howev
virus
often
caus
sever
pneumonia
patient
leukemia
undergo
hematopoiet
stem
cell
transplant
hsct
mainli
decreas
cell
respons
report
case
fatal
pneumonia
viremia
due
human
parainfluenza
viru
type
male
patient
adult
tcell
leukemiaelymphoma
atl
treat
mogamulizumab
male
patient
diagnos
acut
type
atl
eleven
year
chronic
phase
number
white
blood
cell
wbc
lactat
dehydrogenas
ldh
peripher
blood
markedli
increas
iu
l
respect
therefor
combin
regimen
vcap
vincristin
cyclophosphamid
doxorubicin
prednison
amp
doxorubicin
ranimustin
prednison
vecp
vindesin
etoposid
carboplatin
prednison
start
induct
chemotherapi
soon
third
cours
vcapeampevecp
therapi
finish
number
circul
lymphocyt
atl
cell
ldh
solubl
receptor
unfortun
increas
rapidli
suggest
statu
turn
refractori
phase
therefor
introduc
mogamulizumab
dosag
mgkg
per
week
salvag
therapi
base
find
posit
ratio
antigen
atl
cell
treatment
number
neutrophil
lymphocyt
atl
cell
peripher
blood
respect
day
induct
mogamulizumab
atl
cell
disappear
peripher
blood
number
lymphocyt
rapidli
decreas
accompani
prolong
sever
lymphopenia
grade
fig
despit
prophylact
medic
administ
levofloxacin
lvfx
itraconazol
itcz
sulfamethoxazoletrimethoprim
st
acyclovir
acv
suffer
infecti
complic
includ
cmv
antigenemia
gramneg
bacteri
sepsi
aspergillosi
clinic
cours
although
infect
well
control
broad
spectrum
antimicrobi
treatment
multipl
patchi
groundglass
opac
bilater
lung
atyp
pattern
bacteri
pneumonia
appear
gradual
worsen
due
acut
respiratori
failur
die
day
fig
sinc
chest
ct
show
typic
pattern
viral
pneumonia
fig
peripher
blood
collect
premort
examin
multiplex
pcr
kit
seeplex
onestep
ace
detect
seegen
south
korea
screen
crv
includ
influenza
viru
ab
human
adenoviru
coronaviru
parainfluenza
viru
rhinoviru
abc
respiratori
syncyti
rs
viru
ab
bocaviru
metapneumoviru
enteroviru
consequ
rna
detect
blood
diagnos
viremia
due
autopsi
lung
cytoplasm
inclus
bodi
multinucl
syncyti
giant
cell
abundantli
observ
fig
find
commonli
observ
viral
pneumonia
especi
former
find
strongli
suggest
rna
viral
infect
also
hyalin
membran
format
reflect
diffus
alveolar
damag
observ
lung
fig
hand
neutrophil
infiltr
microorgan
includ
bacteria
fungi
observ
also
antigenposit
atl
cell
detect
lung
varieti
tissu
indic
atl
statu
complet
remiss
taken
togeth
final
diagnos
caus
death
sever
pneumonia
due
infect
herein
report
case
fatal
pneumonia
viremia
due
patient
atl
treat
mogamulizumab
one
report
show
human
parainfluenza
viru
type
viremia
patient
acut
myocard
knowledg
case
first
report
document
viremia
due
crv
wide
known
caus
pathogen
upper
respiratori
tract
infect
urti
healthi
subject
howev
crv
also
recogn
caus
lower
respiratori
tract
infect
lrti
high
mortal
rate
patient
leukemia
recipi
hsct
lrti
due
hpiv
occur
patient
leukemia
hsct
recipi
mortal
rate
import
risk
factor
progress
lrti
lymphopenia
although
threshold
vari
accord
studi
lymphocyt
count
less
accept
guidelin
present
case
prolong
sever
lymphopenia
less
consid
possibl
main
caus
develop
fatal
pneumonia
viremia
due
chest
ct
imag
may
help
differenti
bacteri
viral
pneumonia
gener
interstiti
infiltr
includ
multifoc
distribut
groundglass
opac
suggest
viral
pneumonia
regard
hpiv
pneumonia
recent
studi
show
treeinbud
opac
reflect
bronchiol
common
find
follow
bronchial
wall
thicken
groundglass
opac
although
typic
treeinbud
opac
observ
present
case
centrilobular
nodul
suggest
bronchiol
observ
day
find
worsen
diffus
patchi
groundglass
opac
clinic
cours
fig
thu
ct
imag
observ
patient
consist
previou
report
hpiv
pneumonia
ideal
direct
detect
viru
lung
warrant
diagnos
viral
pneumonia
immunostain
antibodi
detect
extract
liquid
lung
tissu
attempt
howev
technic
difficult
detect
lung
rna
gener
unstabl
longterm
fixat
formalin
paraffin
cruel
condit
rna
viru
includ
final
diagnos
pneumonia
base
line
evid
list
detect
blood
ct
imag
consist
viral
pneumonia
patholog
find
suggest
rna
viral
infect
lung
undoubtedli
mogamulizumab
promis
agent
treatment
refractori
atl
howev
robust
cytotox
may
provok
lifethreaten
opportunist
infect
observ
present
case
although
report
show
ribavirin
therapi
without
intraven
immunoglobulin
ivig
effect
treatment
hpiv
infect
establish
antivir
therapi
treatment
hpiv
infect
context
standard
precaut
effect
countermeasur
prevent
infect
spread
hpiv
conclus
report
case
fatal
pneumonia
viremia
due
patient
atl
treat
mogamulizumab
current
case
suggest
prolong
sever
lymphopenia
induc
mogamulizumab
like
let
patient
suscept
infect
